Coreline Soft Co (XKRX:384470) Debt-to-EBITDA : -0.06 (As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Coreline Soft Co Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

Coreline Soft Co's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩670 Mil. Coreline Soft Co's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Mar. 2024 was ₩0 Mil. Coreline Soft Co's annualized EBITDA for the quarter that ended in Mar. 2024 was ₩-11,549 Mil. Coreline Soft Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 was -0.06.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for Coreline Soft Co's Debt-to-EBITDA or its related term are showing as below:

XKRX:384470' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.39 Med: -0.2 Max: -0.06
Current: -0.06

During the past 3 years, the highest Debt-to-EBITDA Ratio of Coreline Soft Co was -0.06. The lowest was -0.39. And the median was -0.20.

XKRX:384470's Debt-to-EBITDA is ranked worse than
100% of 101 companies
in the Medical Diagnostics & Research industry
Industry Median: 1.76 vs XKRX:384470: -0.06

Coreline Soft Co Debt-to-EBITDA Historical Data

The historical data trend for Coreline Soft Co's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Coreline Soft Co Debt-to-EBITDA Chart

Coreline Soft Co Annual Data

Trend

Dec20

Dec21

Dec22

Debt-to-EBITDA

-0.39

-0.20

-0.14

Coreline Soft Co Quarterly Data
	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Debt-to-EBITDA	Get a 7-Day Free Trial			-0.15	-	-0.09	-0.19	-0.06

Competitive Comparison of Coreline Soft Co's Debt-to-EBITDA

For the Diagnostics & Research subindustry, Coreline Soft Co's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Coreline Soft Co's Debt-to-EBITDA Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Coreline Soft Co's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Coreline Soft Co's Debt-to-EBITDA falls into.

Coreline Soft Co Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

Coreline Soft Co's Debt-to-EBITDA for the fiscal year that ended in Dec. 2022 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(827.887	+	455.97)	/	-9377.901
	=	-0.14

Coreline Soft Co's annualized Debt-to-EBITDA for the quarter that ended in Mar. 2024 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(669.818	+	0)	/	-11548.724
	=	-0.06

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is four times the quarterly (Mar. 2024) EBITDA data.

Coreline Soft Co (XKRX:384470) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

Coreline Soft Co Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Coreline Soft Co's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

Coreline Soft Co (XKRX:384470) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Coreline Soft Co Ltd (XKRX:384470) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

49, Worldcupbuk-ro 6-gil, Mapo-gu, 4th and 5th floors, Yeonnam-dong, Seoul, KOR

Website

https://www.corelinesoft.com

Coreline Soft Co Ltd is an Artificial Intelligence-based 3D medical image analysis solution company. Their core technology is XAI (Explainable AI) technology, which assists diagnosis by fully automatically and accurately quantitatively analyzing 3D medical images and providing results and supporting data to medical staff. The company's main product is a solution used to assist medical staff in diagnosis or support treatment and research by analyzing CT (Computerized Tomography) images of the chest, head and neck, etc.

Coreline Soft Co (XKRX:384470) Headlines

No Headlines